In CY 2025 PFS rule (89 FR 97722), we stated that in light of the AMA's current data collection efforts and because the methodological and data source changes to the 2017-based MEI finalized in the CY 2023 PFS final rule would have significant impacts on PFS payments, similar to our discussion of this topic in the CY 2024 PFS rule cycle (88 FR 78829 through 78831), we continued to believe that delaying the implementation of the finalized 2017-based MEI cost share weights for the RVUs was consistent with our efforts to balance payment stability and predictability with incorporating new data through more routine updates
Its not FDA-approved as a drug, and its not a controlled substance under federal law, which puts it in a gray zone
Why researchers look at Cagrilintide Interest in Cagrilintide is typically connected to appetite signaling, glucose handling, satiety, body composition, and energy regulation
This suggests a link between homocysteine and the generation of plaques
We reported the first reversible reaction-based small-molecule fluorescent GSH probe (ThiolQuant Green) that can perform single-point quantification of GSH levels in living cells 15
